No products in the cart.

Anti-HER4/ErbB4 antibody

SKU Product Brand Unit Availability Price Quantity  
AB-06-2140
Anti-HER4/ErbB4 antibody
Erpan Tech In stock

Specifications        

Product Cat#: AB-06-2140
Product type: Primary antibody
Antigen: HER4/ErbB4
Immunogen: Amino acids 1280-1308 at C-terminus of ErbB-4 of human origin.
Species immunized: Mouse
Isotype: IgG1
Applications: Western Blot (1:200-1:1000); Immunohistochemistry (1:100-1:500); Immunofluorescence(1:50-1:500); Flow Cytometry: 1 μg per 1 x 106 cells; Immunoprecipitation: 1-2 μg per 100-500 μg of total protein (1 ml of cell lysate)
Reactivity: Mouse, Rat and Human
Clonality (clone number): Monoclonal  (4G19)
Form: Liquid
Buffer: 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
Concentration: 1 mg/ml
Purity: Protein A affinity purified
Storage: Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles.
Alternative names: 4ICD antibody
ALS19 antibody
Avian erythroblastic leukemia viral oncogene homolog 4 antibody
Avian erythroblastic leukemia viral v erb b2 oncogene homolog 4 antibody
E4ICD antibody
Show More

Target information

Tyrosine-protein kinase that plays an essential role as cell surface receptor for neuregulins and EGF family members and regulates development of the heart, the central nervous system and the mammary gland, gene transcription, cell proliferation, differentiation, migration and apoptosis. Required for normal cardiac muscle differentiation during embryonic development, and for postnatal cardiomyocyte proliferation. Required for normal development of the embryonic central nervous system, especially for normal neural crest cell migration and normal axon guidance. Required for mammary gland differentiation, induction of milk proteins and lactation. Acts as cell-surface receptor for the neuregulins NRG1, NRG2, NRG3 and NRG4 and the EGF family members BTC, EREG and HBEGF. Ligand binding triggers receptor dimerization and autophosphorylation at specific tyrosine residues that then serve as binding sites for scaffold proteins and effectors. Ligand specificity and signaling is modulated by alternative splicing, proteolytic processing, and by the formation of heterodimers with other ERBB family members, thereby creating multiple combinations of intracellular phosphotyrosines that trigger ligand- and context-specific cellular responses. Mediates phosphorylation of SHC1 and activation of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1. Isoform JM-A CYT-1 and isoform JM-B CYT-1 phosphorylate PIK3R1, leading to the activation of phosphatidylinositol 3-kinase and AKT1 and protect cells against apoptosis. Isoform JM-A CYT-1 and isoform JM-B CYT-1 mediate reorganization of the actin cytoskeleton and promote cell migration in response to NRG1. Isoform JM-A CYT-2 and isoform JM-B CYT-2 lack the phosphotyrosine that mediates interaction with PIK3R1, and hence do not phosphorylate PIK3R1, do not protect cells against apoptosis, and do not promote reorganization of the actin cytoskeleton and cell migration. Proteolytic processing of isoform JM-A CYT-1 and isoform JM-A CYT-2 gives rise to the corresponding soluble intracellular domains (4ICD) that translocate to the nucleus, promote nuclear import of STAT5A, activation of STAT5A, mammary epithelium differentiation, cell proliferation and activation of gene expression. The ERBB4 soluble intracellular domains (4ICD) colocalize with STAT5A at the CSN2 promoter to regulate transcription of milk proteins during lactation. The ERBB4 soluble intracellular domains can also translocate to mitochondria and promote apoptosis.

Provider

Erpantech Laboratory

download

MSDS-AB-06-2140.pdf (178 downloads)